Like big pharma, biotech is toxic: Trader

Health care is one of the biggest drags on the market right now because of the moves lower in biotech stocks. CNBC's Meg Tirrell looks ahead to biotech earnings out next week. The FMHR traders and Kate Moore, JPMorgan Private Bank chief investment strategist, discuss.